What is the Nifty Pharma Index value today?
The latest value of Nifty Pharma Index is 24969.50 as of 25th June 2026.What is the shareholder returns of Nifty Pharma Index Index?
The Nifty Pharma Index has given the following returns in the past:- Past 1 week | 3.29%
- Past 1 month | 1.44%
- Past 3 months | 10.10%
- Past 6 months | 10.07%
- Past 1 year | 14.51%
- Past 3 years | 89.36%
- Past 5 years | 77.47%
What is the 52 week high value of Nifty Pharma Index?
The 52 week high value of Nifty Pharma Index is 25294.50, as of 25th June 2026.What is the 52 week low value of Nifty Pharma Index?
The 52 week low value of Nifty Pharma Index is 21149.90, as of 25th June 2026.What are the components of Nifty Pharma Index?
The components of Nifty Pharma Index, along with their weightage, are as follows -- Sun Pharmaceutical Industries Ltd | 22.46%
- Divi's Laboratories Ltd | 9.68%
- Dr Reddy's Laboratories Ltd | 8.94%
- Cipla Ltd | 8.62%
- Lupin Ltd | 6.43%
N
Nifty Pharma Index Today
NIFTY PHARMA Share Price
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ETFs tracking NIFTY PHARMA
PHARMABEES
NIFTY PHARMA Performance & Key Metrics
NIFTY PHARMA Performance & Key Metrics
| PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 36.66 | 4.94 | 0.66% |
| Market Cap ShareM Cap Share | ConstituentsConstituents | ETFsETFs |
|---|---|---|
| 4.04% | 20 | 1 |
About NIFTY PHARMA
About NIFTY PHARMA
Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Get more out of Tickertape, Go Pro!
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
Free float marketcap values in ₹ thousand cr.
| Stocks | 1D change | Return attribution | Index weight | Free float marketcap | |
|---|---|---|---|---|---|
| NIFTY PHARMA 1D return-0.20% | 0.20% | -0.20% | 100.00% | Free float Mcap883.24 Weight100.00% | |
ABBOTINDIA 0.04% Return attribution-0.00% | 0.04% | -0.00% | 1.51% | 13.29 Weight1.51% | |
ALKEM 0.06% Return attribution-0.00% | 0.06% | -0.00% | 2.72% | 24.06 Weight2.72% | |
AJANTPHARM 2.31% Return attribution-0.04% | 2.31% | -0.04% | 1.65% | 14.55 Weight1.65% | |
BIOCON 1.07% Return attribution-0.04% | 1.07% | -0.04% | 3.42% | 30.22 Weight3.42% | |
AUROPHARMA 1.61% Return attribution0.07% | 1.61% | 0.07% | 4.58% | 40.42 Weight4.58% | |
DRREDDY 1.66% Return attribution0.15% | 1.66% | 0.15% | 8.94% | 78.98 Weight8.94% | |
ZYDUSLIFE 0.19% Return attribution0.01% | 0.19% | 0.01% | 3.01% | 26.56 Weight3.01% | |
DIVISLAB 0.59% Return attribution-0.06% | 0.59% | -0.06% | 9.68% | 85.52 Weight9.68% | |
CIPLA 0.15% Return attribution0.01% | 0.15% | 0.01% | 8.62% | 76.12 Weight8.62% | |
GLENMARK 1.20% Return attribution-0.04% | 1.20% | -0.04% | 3.51% | 31.03 Weight3.51% | |
IPCALAB 0.18% Return attribution-0.00% | 0.18% | -0.00% | 2.55% | 22.55 Weight2.55% | |
J B Chemicals and Pharmaceuticals Ltd JBCHEPHARM 0.49% Return attribution0.01% | 0.49% | 0.01% | 2.07% | 18.29 Weight2.07% | |
LUPIN 1.02% Return attribution-0.07% | 1.02% | -0.07% | 6.43% | 56.76 Weight6.43% | |
LAURUSLABS 0.29% Return attribution-0.02% | 0.29% | -0.02% | 6.03% | 53.24 Weight6.03% | |
Sun Pharmaceutical Industries Ltd SUNPHARMA 0.62% Return attribution-0.14% | 0.62% | -0.14% | 22.46% | 198.40 Weight22.46% | |
TORNTPHARM 0.26% Return attribution0.01% | 0.26% | 0.01% | 4.99% | 44.04 Weight4.99% | |
WOCKPHARMA 0.16% Return attribution-0.00% | 0.16% | -0.00% | 1.77% | 15.64 Weight1.77% | |
GLAND 0.49% Return attribution-0.01% | 0.49% | -0.01% | 2.09% | 18.42 Weight2.09% | |
PPLPHARMA 2.75% Return attribution-0.03% | 2.75% | -0.03% | 1.15% | 10.13 Weight1.15% | |
MANKIND 0.83% Return attribution-0.02% | 0.83% | -0.02% | 2.83% | 25.02 Weight2.83% |
ETFs tracking NIFTY PHARMA Index
ETFs tracking NIFTY PHARMA Index
| ETFs | Price | Liquidity | Expense ratio | Tracking error | |
|---|---|---|---|---|---|
PHARMABEES — | — | High | 0.21% | 0.02% |
NIFTY PHARMA Events
NIFTY PHARMA Events
Dividends
Corp. Actions
Announcements
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
NIFTY PHARMA Upcoming Dividends
NIFTY PHARMA Upcoming Dividends
Cash DividendABBOTINDIA
ABBOTINDIAEx DateEx DateJul 24, 2026
Special
Special | Div/Share: ₹131.00
Dividend/Share
₹131.00
Ex DateEx Date
Jul 24, 2026
Cash DividendABBOTINDIA
ABBOTINDIAEx DateEx DateJul 24, 2026
Final
Final | Div/Share: ₹525.00
Dividend/Share
₹525.00
Ex DateEx Date
Jul 24, 2026
Cash DividendZYDUSLIFE
ZYDUSLIFEEx DateEx DateJul 24, 2026
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Jul 24, 2026
Cash DividendDIVISLAB
DIVISLABEx DateEx DateJul 24, 2026
Final
Final | Div/Share: ₹30.00
Dividend/Share
₹30.00
Ex DateEx Date
Jul 24, 2026
Cash DividendDRREDDY
DRREDDYEx DateEx DateJul 10, 2026
Final
Final | Div/Share: ₹8.00
Dividend/Share
₹8.00
Ex DateEx Date
Jul 10, 2026
NIFTY PHARMA Past Dividends
NIFTY PHARMA Past Dividends
Cash DividendCIPLA
CIPLAEx DateEx DateJun 5, 2026
Final
Final | Div/Share: ₹13.00
Dividend/Share
₹13.00
Ex DateEx Date
Jun 5, 2026
Cash DividendJBCHEPHARM
JBCHEPHARMEx DateEx DateMay 29, 2026
Final
Final | Div/Share: ₹9.30
Dividend/Share
₹9.30
Ex DateEx Date
May 29, 2026
Cash DividendTORNTPHARM
TORNTPHARMEx DateEx DateMay 29, 2026
Final
Final | Div/Share: ₹9.00
Dividend/Share
₹9.00
Ex DateEx Date
May 29, 2026
Cash DividendLAURUSLABS
LAURUSLABSEx DateEx DateMay 8, 2026
Interim 2
Interim 2 | Div/Share: ₹1.20
Dividend/Share
₹1.20
Ex DateEx Date
May 8, 2026
Cash DividendALKEM
ALKEMEx DateEx DateFeb 20, 2026
Interim
Interim | Div/Share: ₹43.00
Dividend/Share
₹43.00
Ex DateEx Date
Feb 20, 2026
NIFTY PHARMA News & Opinions
NIFTY PHARMA News & Opinions
Articles & Videos
Centre Proposes Simpler Drug Import Rules For Small-Quantity Testing, Research And Analysis
55 minutes ago•Free Press Journal
India pharma sector shifts focus to biosimilars, biologics and high-value growth
2 days ago•The Hindu Businessline
NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chain
2 days ago•Economic Times
India’s pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI Aayog
3 days ago•Economic Times
IT selloff drags Nifty below 24,000; pharma stocks buck the trend
3 days ago•The Hindu Businessline
Biosimilars and innovation will drive Indian pharma’s next growth phase: Vishal Manchanda
3 days ago•Economic Times
Sensex Gains 291 Points, Nifty Closes Above 24,100 As IT And Pharma Stocks Lead Rally
4 days ago•Free Press Journal
Sun Pharmaceutical to buy Innovcare Lifesciences for ₹271 crore
6 days ago•The Hindu Businessline
API prices fall as West Asia tensions ease, boosting Indian pharma sector
1 week ago•Economic Times
Ahead of Market: 10 things that will decide stock market action on Friday
2 weeks ago•Economic Times
